Emergency MedicineNoninvasive, low-cost CGM for type 2 diabetes coming in U.S. and EUDecember 2, 2020Endocrinology
Emergency MedicineNew AHA scientific statement on menopause and CVD riskDecember 2, 2020CardiologyEndocrinologyMixed Topics
Blood glucose on admission predicts COVID-19 severity in allNovember 30, 2020COVID-19 UpdatesEndocrinologyCardiology
Emergency MedicineDon’t miss cardiovascular risk factors in transgender patientsNovember 13, 2020CardiologyEndocrinology
New eGFR equation ‘less biased’ by age, kidney function; some disagreeNovember 10, 2020EndocrinologyMixed TopicsGastroenterology
Emergency MedicineNo link shown between thyroid dysfunction and heart failureNovember 10, 2020CardiologyEndocrinology
Emergency MedicineFirst-of-its kind guideline on lipid monitoring in endocrine diseasesNovember 6, 2020Endocrinology
Emergency MedicineConsensus guidelines address inpatient diabetes technologyOctober 29, 2020EndocrinologyCOVID-19 Updates
Emergency MedicineVertebral fractures in COVID-19 linked to mortalityOctober 28, 2020COVID-19 UpdatesPulmonologyEndocrinologyInfectious Diseases
Emergency Medicine‘Modest’ benefit for post-MI T2D glucose monitoringOctober 20, 2020CardiologyEndocrinology
Emergency MedicineCOVID-19 antibody response not reduced with diabetesOctober 20, 2020COVID-19 UpdatesInfectious DiseasesEndocrinology
Emergency MedicineT2D treatments create tension between glycemic and cardiovascular goalsOctober 12, 2020CardiologyEndocrinology
Emergency MedicineEmpagliflozin cut PA pressures in heart failure patientsOctober 12, 2020CardiologyPulmonologyEndocrinology
Emergency MedicineEMPEROR-Reduced: Empagliflozin’s HFrEF benefit holds steady on top of sacubitril/valsartanOctober 6, 2020CardiologyEndocrinology
